Reference no: EM133804899

Question

An 85-year-old woman comes to your community health clinic seeking medication for her mild cognitive impairment diagnosis. Her daughter accompanies her to the clinic and is requesting Namenda specifically for her mother's memory problems. She reports she saw an ad for it on TV and knows that it will help her mother. What answer would you give the patient and her daughter about Namenda? Group of answer choices Namenda (memantine) is not FDA-approved for mild cognitive decline, only for moderate to severe Alzheimer's disease. A cholinesterase inhibitor may be appropriate for her mother, if tolerated. It is bad practice to ever prescribed medications that are specifically requested by patients and family after seeing advertisements. Namenda would be an appropriate choice for the patient as long as she can tolerate the medication without significant side effects. The most common of these would be dizziness, headache and constipation. No medications are are appropriate for a diagnosis of mild cognitive impairment. Only more severe forms of dementia should be treated with medication.